Antibody response to SARS-CoV-2 in people living with HIV

• Shinya Yamamoto,
• Makoto Saito,
• Etsuko Nagai,
• Keiko Toriuchi,
• Hiroyuki Nagai,
• Hiroshi Yotsuyanagi,
• Yu Nakagama,
• Yasutoshi Kido,
• Eisuke Adachi

Affiliations

Shinya Yamamoto

Department of Infectious Diseases and Applied Immunology, Institute of Medical Science, The University of Tokyo, Tokyo, Japan

Makoto Saito

Department of Infectious Diseases and Applied Immunology, Institute of Medical Science, The University of Tokyo, Tokyo, Japan

Etsuko Nagai

Department of Infectious Diseases and Applied Immunology, Institute of Medical Science, The University of Tokyo, Tokyo, Japan

Keiko Toriuchi

Department of Infectious Diseases and Applied Immunology, Institute of Medical Science, The University of Tokyo, Tokyo, Japan

Hiroyuki Nagai

Department of Infectious Diseases and Applied Immunology, Institute of Medical Science, The University of Tokyo, Tokyo, Japan

Hiroshi Yotsuyanagi

Department of Infectious Diseases and Applied Immunology, Institute of Medical Science, The University of Tokyo, Tokyo, Japan

Yu Nakagama

Department of Parasitology, Graduate Scholl of Medicine, Osaka City University, Osaka, Japan

Yasutoshi Kido

Department of Parasitology, Graduate Scholl of Medicine, Osaka City University, Osaka, Japan

Eisuke Adachi

Corresponding author. Department of Infectious Diseases and Applied Immunology, IMSUT Hospital of The Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo, Japan.; Department of Infectious Diseases and Applied Immunology, Institute of Medical Science, The University of Tokyo, Tokyo, Japan